Diagnostic and prognostic potential of extracellular vesicles in peripheral blood

Clinical Therapeutics

Volumn 36, Issue 6, 2014, Pages 830-846

  Revenfeld, Anne Louise Schacht ^a   Bæk, Rikke ^b   Nielsen, Morten Hjuler ^b   Stensballe, Allan ^a   Varming, Kim ^b   Jørgensen, Malene ^b  

^a AALBORG UNIVERSITY   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Diagnostics; Enumeration; Exosomes; Extracellular vesicles; Microvesicles; Phenotyping; RNA cargo

Indexed keywords

BIOLOGICAL MARKER; LIPID; MICRORNA; PROTEIN; RNA;

ANALYTIC METHOD; APOPTOTIC BODY; BLOOD; CELL COMMUNICATION; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EXOSOME; FLOW CYTOMETRY; HUMAN; IMMUNE SYSTEM; MEMBRANE VESICLE; MICROARRAY ANALYSIS; MICROVESICLE; NANOPARTICLE TRACKING ANALYSIS; NUCLEAR MAGNETIC RESONANCE; PHENOTYPE; PROGNOSIS; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RISK ASSESSMENT; SCANNING ION OCCLUSION SENSING; WESTERN BLOTTING; APOPTOSIS; CHEMISTRY; IMMUNOPHENOTYPING; METABOLISM; NEOPLASM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

APOPTOSIS; BIOMARKERS; EXOSOMES; EXTRACELLULAR VESICLES; HUMANS; IMMUNOPHENOTYPING; MAGNETIC RESONANCE SPECTROSCOPY; MICRORNAS; NEOPLASMS; PHENOTYPE; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84902823826     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2014.05.008     Document Type: Review

References (126)

1. Akers JC, Gonda D, Kim R, et al. Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies. J Neurooncol. 2013;113:1-11.
2. Andaloussi SEL, Mager I, Breakefield XO, et al. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov. 2013;12:347-357.
3. Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013;200:373-383.
4. Gyorgy B, Szabo TG, Pasztoi M, et al. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci. 2011;68:2667-2688.
5. Cocucci E, Racchetti G, Meldolesi J. Shedding micro-vesicles: artefacts no more. Tren ds Ce ll Bio l. 2009;19:43-51 .
6. Thery C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009;9:581-593.
7. Mathivanan S, Ji H, Simpson RJ. Exosomes: extracellular organelles important in intercellular communication. J Proteomics. 2010;73:1907-1920.
8. Vlassov AV, Magdaleno S, Setterquist R, et al. Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta. 2012;1820:940-948.
9. Pant S, Hilton H, Burczynski ME. The multifaceted exosome: biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities. Biochem Pharmacol. 2012;83:1484-1494.
10. Distler JH, Huber LC, Gay S, et al. Microparticles as mediators of cellular cross-talk in inflammatory disease. Autoimmunity. 2006;39:683-690. (Pubitemid 44964371)
11. Villarroya-Beltri C, Gutierrez-Vazquez C, Sanchez-Madrid F, et al. Analysis of microRNA and protein transfer by exosomes during an immune synapse. Methods Mol Biol. 2013;1024:41-51.
12. Noltet Hoen EN, Buschow SI, Anderton SM, et al. Activated T cells recruit exosomes secreted by dendritic cells via LFA-1. Blood. 2009;113:1977-1981.
13. Arnold PY, Mannie MD. Vesicles bearing MHC class II molecules mediate transfer of antigen from antigen-presenting cells to CD4 T cells. Eur J Immunol. 1999;29:1363- 1373. (Pubitemid 29164183)
14. Choudhuri K, Llodra J, Roth EW, et al. Polarized release of T-cell-receptor-enriched microvesicles at the immunological synapse. Nature. 2014;507:118-123.
15. Mittelbrunn M, Gutierrez-Vazquez C, Villarroya-Beltri C, et al. Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat Com-mun. 2011;2:282.
16. Valadi H, Ekstrom K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9:654-659. (Pubitemid 47214727)
17. Skog J, Wurdinger T, van Rijn S, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008;10:1470-1476.
18. Muralidharan-Chari V, Clancy JW, Sedgwick A, et al. Microvesicles: mediators of extracellular communication during cancer progression. J Cell Sci. 2010;123(pt 10):1603- 1611 .
19. Lynch SF, Ludlam CA. Plasma mi-croparticles and vascular disorders. Br J Haematol. 2 007;137:36-48.
20. Abid Hussein MN, Meesters EW, Osmanovic N, et al. Antigenic characterization of endothelial cell-derived microparticles and their detection ex vivo. J Thromb Haemost. 2003;1:2434-2443.
21. Nielsen MH, Beck-Nielsen H, Andersen MN, et al. A flow cytometric method for characterization of circulating cell-derived microparticles in plasma. J Extracell Vesicles. 2014 Feb 24. [Epub ahead of print].
22. Connor DE, Exner T, Ma DD, et al. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib. Thromb Haemost. 2010;103:1044-1052.
23. Jimenez JJ, Jy W, Mauro LM, et al. Endothelial cells release phenotypi-cally and quantitatively distinct microparticles in activation and apoptosis. Thromb Res. 2003;109: 175 -180. (Pubitemid 36712905)
24. Perez-Pujol S, Marker PH, Key NS. Platelet microparticles are heterogeneous and highly dependent on the activation mechanism: studies using a new digital flow cytometer. Cytometry A. 2007;71:38-45. (Pubitemid 46207382)
25. Muralidharan-Chari V, Clancy J, Plou C, et al. ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles. Curr Biol. 2009;19:1875-1885.
26. Berda-Haddad Y, Robert S, Salers P, et al. Sterile inflammation of endothelial cell-derived apoptotic bodies is mediated by interleukin-1alpha. Proc Natl Acad Sci U S A. 2011;108:20684-20689.
27. Hristov M, Erl W, Linder S, et al. Apoptotic bodies from endothelial cells enhance the number and initiate the differentiation of human endothelial progenitor cells in vitro. Blood. 2004;104:2761-2766. (Pubitemid 39434959)
28. Cline AM, Radic MZ. Apoptosis, subcellular particles, and autoim-munity. Clin Immunol. 2004;112: 175 -182.
29. Pan BT, Johnstone RM. Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell. 1983;33:967-978.
30. Harding C, Heuser J, Stahl P. Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulo-cytes. J Cell Biol. 1983;97:329-339.
31. Admyre C, Johansson SM, Paulie S, et al. Direct exosome stimulation of peripheral human T cells detected by ELISPOT. Eur J Immunol. 2006;36:1772-1781. (Pubitemid 44089044)
32. Eldh M, Ekstrom K, Valadi H, et al. Exosomes communicate protective messages during oxidative stress; possible role of exosomal shuttle RNA. PLoS One. 2010;5: e15353.
33. Saunderson SC, Schuberth PC, Dunn AC, et al. Induction of exosome release in primary B cells stimulated via CD40 and the IL-4 receptor. J Immunol. 2008;180:8146-8152.
34. Buschow SI, Nolte-'t Hoen EN, van Niel G, et al. MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways. Tra f fi c. 2009;10:1528-1542.
35. Wurdinger T, Gatson NN, Balaj L, et al. Extracellular vesicles and their convergence with viral pathways. Adv Virol. 2012;2012:767694.
36. Mack M, Kleinschmidt A, Bruhl H, et al. Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection. Nat Med. 2000;6:769-775. (Pubitemid 30469425)
37. Bhatnagar S, Shinagawa K, Castel-lino FJ, et al. Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo. Blood. 2007;110: 3234-3244. (Pubitemid 350106316)
38. Rak J, Guha A. Extracellular vesicles - vehicles that spread cancer genes. Bioessays. 2012;34:489-497.
39. Abusamra AJ, Zhong Z, Zheng X, et al. Tumor exosomes expressing Fas ligand mediate CD8 T-cell apoptosis. Blood Cells Mol Dis. 2005;35:169-173. (Pubitemid 41267045)
40. Wieckowski EU, Visus C, Szajnik M, et al. Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8 T lymphocytes. J Immunol. 2009;183: 3720-3730.
41. Szajnik M, Czystowska M, Szcze-panski MJ, et al. Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg). PLoS One. 2010;5:e11469.
42. Al-Nedawi K, Meehan B, Micallef J, et al. Intercellular transfer of the oncogenic receptor EGFRvIII by mi-crovesicles derived from tumour cells. Nat Cell Biol. 2008;10:619-624. (Pubitemid 351627382)
43. Szajnik M, Derbis M, Lach M, et al. Exosomes in plasma of patients with ovarian carcinoma: potential biomarkers of tumor progression and response to therapy. Gynecol Obstet (Sunnyvale). 2013;(Suppl 4):3.
44. Baran J, Baj-Krzyworzeka M, Weglarczyk K, et al. Circulating tumour-derived microvesicles in plasma of gastric cancer patients. Cancer Immunol Immunother. 2009; 59:841-850.
45. Kim HK, Song KS, Park YS, et al. Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur J Cancer. 2003;39:184-191. (Pubitemid 36057068)
46. Rabinowits G, Gercel-Taylor C, Day JM, et al. Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer. 2009;10:42-46.
47. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics. 2002;1 (11):845-867.
48. Hortin GL, Sviridov D. The dynamic range problem in the analysis of the plasma proteome. J Proteomics. 2010;73:629-636.
49. Li J, Sherman-Baust CA, Tsai-Turton M, et al. Claudin-containing exo-somes in the peripheral circulation of women with ovarian cancer. BMC Cancer. 2009;9:244.
50. Tanaka Y, Kamohara H, Kinoshita K, et al. Clinical impact of serum exosomal microRNA21 as a clinical biomarker in human esophageal squamous cell carcinoma. Cancer. 2013;119:1159-1167 .
51. Hu Z, Chen X, Zhao Y, et al. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol. 2010;28:1721-1726.
52. Satzger I, Mattern A, Kuettler U, et al. MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma. Int J Cancer.
53. Ng EK, Chong WW, Jin H, et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for color-ectal cancer screening. Gut. 2009;58: 1375 -1381 .
54. Lawrie CH, Gal S, Dunlop HM, et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Hae-matol. 2008;141:672-675. (Pubitemid 351667616)
55. Resnick KE, Alder H, Hagan JP, et al. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol. 2009;112:55-59.
56. Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008;18:997- 1006.
57. Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105:10513-10518.
58. Zhu W, Qin W, Atasoy U, et al. Circulating microRNAs in breast cancer and healthy subjects. BMC Res Notes. 2009;2:89.
59. Segura MF, Hanniford D, Menen-dez S, et al. Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proc Natl Acad Sci U S A. 2009;106:1814-1819.
60. Keller S, Konig AK, Marme F, et al. Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes. Cancer Lett. 2009;278:73-81.
61. Shao H, Chung J, Balaj L, et al. Protein typing of circulating micro-vesicles allows real-time monitoring of glioblastoma therapy. Nat Med. 2012;18:1835-1840.
62. Logozzi M, De Milito A, Lugini L, et al. High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS One. 2009;4:e5219.
63. Kim JW, Wieckowski E, Taylor DD, et al. Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes. Clin Cancer Res. 2005;11: 1010-1020. (Pubitemid 40175748)
64. Tesselaar ME, Romijn FP, Van Der Linden IK, et al. Microparticle- associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost. 2007;5:520- 527. (Pubitemid 46680685)
65. Matsubara E, Shoji M, Murakami T, et al. Platelet microparticles as carriers of soluble Alzheimer's amyloid beta (sAbeta). Ann N Y Acad Sci. 2002;977:340-348. (Pubitemid 35418174)
66. Witwer KW, Buzas EI, Bemis LT, et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles. 27 May 2013. [Epub ahead of print].
67. Momen-Heravi F, Balaj L, Alian S, et al. Current methods for the isolation of extracellular vesicles. Biol Chem. 2013;394:1253-1262.
68. van der Pol E, Boing AN, Harrison P, et al. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev. 2012;64: 676-705.
69. Gyorgy B, Modos K, Pallinger E, et al. Detection and isolation of cell-derived microparticles are compromised by protein complexes resulting from shared biophysical parameters. Blood. 2011;117:e39-e48.
70. Moldovan L, Batte K, Wang Y, et al. Analyzing the circulating mi-croRNAs in exosomes/extracellular vesicles from serum or plasma by qRT-PCR. Methods Mol Biol. 2013;1024:129-145.
71. Tauro BJ, Greening DW, Mathias RA, et al. Comparison of ultracen-trifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. Methods. 2012;56:293- 304.
72. Peters PJ, Neefjes JJ, Oorschot V, et al. Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature. 1991;349:669-676. (Pubitemid 21912130)
73. Escola JM, Kleijmeer MJ, Stoorvo-gel W, et al. Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endo-somes and on exosomes secreted by human B-lymphocytes. J Biol Chem. 1998;273:20121-20127. (Pubitemid 28377568)
74. Joergensen M, Baek R, Pedersen S, et al. Extracellular Vesicle (EV) Array: microarray capturing of exo-somes and other extracellular vesicles for multiplexed phenotyp-ing. J Extracell Vesicles. 2013 June 18. [Epub ahead of print].
75. Stoorvogel W, Geuze HJ, Griffith JM, et al. Relations between the intracellular pathways of the receptors for transferrin, asialoglycopro-tein, and mannose 6-phosphate in human hepatoma cells. J Cell Biol. 1989;108:2137-2148. (Pubitemid 19168907)
76. Stoorvogel W, Oorschot V, Geuze HJ. A novel class of clathrin-coated vesicles budding from endosomes. J Cell Biol. 1996;132:21-33. (Pubitemid 26035072)
77. Blanchard N, Lankar D, Faure F, et al. TCR activation of human T cells induces the production of exosomes bearing the TCR/CD3/zeta complex. J Immunol. 2002;168: 3235-3241. (Pubitemid 34250383)
78. Raposo G, Nijman HW, Stoorvogel W, et al. B lymphocytes secrete antigen-presenting vesicles. J Exp Med. 1996;183:1161-1172 .
79. Heijnen HF, Schiel AE, Fijnheer R, et al. Activated platelets release two types of membrane vesicles: micro-vesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood. 1999;94:3791-37.
80. Lasser C, Eldh M, Lotvall J. Isolation and characterization of RNA-containing exosomes. J Vis Exp. 2012(59):e3037.
81. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
82. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979;76:4350-4354. (Pubitemid 9256559)
83. Renart J, Reiser J, Stark GR. Transfer of proteins from gels to diazobenzyloxymethyl-paper and detection with antisera: a method for studying antibody specificity and antigen structure. Proc Natl Acad Sci U S A. 1979;76:3116-3120. (Pubitemid 9233242)
84. Li Y, Jiang T, Zhang J, et al. Elevated serum antibodies against insulinlike growth factor-binding protein-2 allow detecting early-stage cancers: evidences from glioma and colorectal carcinoma studies. Ann Oncol. 2012;23:2415-2422.
85. Jy W, Horstman LL, Jimenez JJ, et al. Measuring circulating cell-derived microparticles. J Thromb Haemost. 2004;2:1842-1851. (Pubitemid 40197488)
86. Kesimer M, Scull M, Brighton B, et al. Characterization of exosome-like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defense. FASEB J. 2009;23:1858-1868.
87. Mobarrez F, Antovic J, Egberg N, et al. A multicolor flow cytometric assay for measurement of platelet-derived microparticles. Thromb Res. 2010;125:e110-e116.
88. Orozco AF, Lewis DE. Flow cyto-metric analysis of circulating mi-croparticles in plasma. Cytometry A. 2010;77:502-514.
89. Caby MP, Lankar D, Vincendeau-Scherrer C, et al. Exosomal-like vesicles are present in human blood plasma. Int Immunol. 2005; 17:879-887. (Pubitemid 41417955)
90. Silva J, Garcia V, Rodriguez M, et al. Analysis of exosome release and its prognostic value in human colorectal cancer. Genes Chromosomes Cancer. 2012;51:409-418.
91. Lacroix R, Robert S, Poncelet P, et al. Overcoming limitations of microparticle measurement by flow cytometry. Semin Thromb Hemost. 2010;36:807-818.
92. Gelderman MP, Simak J. Flow cytometric analysis of cell membrane microparticles. Methods Mol Biol. 2008;484:79-93.
93. Shet AS, Key NS, Hebbel RP. Measuring circulating cell-derived microparticles. J Thromb Haemost. 2004;2:1848-1850.
94. Robert S, Poncelet P, Lacroix R, et al. Standardization of platelet-derived microparticle counting using calibrated beads and a Cytom-ics FC500 routine flow cytometer: a first step towards multicenter studies? J Thromb Haemost. 2009; 7:190-197.
95. Lee H, Sun E, Ham D, et al. Chip-NMR biosensor for detection and molecular analysis of cells. Nat Med. 2008;14:869-874.
96. Issadore D, Min C, Liong M, et al. Miniature magnetic resonance system for point-of-care diagnostics. Lab Chip. 2011;11:2282-2287.
97. Haun JB, Castro CM, Wang R, et al. Micro-NMR for rapid molecular analysis of human tumor samples. Sci Transl Med. 2011;3. 7116.
98. Melton L. Protein arrays: proteo-mics in multiplex. Nature. 2004; 429:101-107.
99. Hall DA, Ptacek J, Snyder M. Protein microarray technology. Mech Ageing Dev. 2007;128:161-167. (Pubitemid 46073070)
100. Soo CY, Song Y, Zheng Y, et al. Nanoparticle tracking analysis monitors microvesicle and exosome secretion from immune cells. Immunology. 2012;136:192-197.
101. Gardiner C, Ferreira YJ, Dragovic RA, et al. Extracellular vesicle sizing and enumeration by nanoparticle tracking analysis. J Extracell Vesicles. 2013 Feb 15. [Epub ahead of print].
102. Momen-Heravi F, Balaj L, Alian S, et al. Alternative methods for characterization of extracellular vesicles. Front Physiol. 2012;3:354.
103. Dragovic RA, Gardiner C, Brooks AS, et al. Sizing and phenotyping of cellular vesicles using Nanopar-ticle Tracking Analysis. Nanomedi-cine. 2011;7:780-788.
104. Filipe V, Hawe A, Jiskoot W. Critical evaluation of Nanoparticle Tracking Analysis (NTA) by Nano-Sight for the measurement of nanoparticles and protein aggregates. Pharm Res. 2010;27:796-810.
105. Garza-Licudine E, Deo D, Yu S, et al. Portable nanoparticle quantization using a resizable nanopore instrument - the IZON qNano. Conf Proc IEEE Eng Med Biol Soc. 2010; 2010:5736-5739.
106. Kosaka N, Iguchi H, Yoshioka Y, et al. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem. 2010; 285:17442-17452.
107. Kogure T, Lin WL, Yan IK, et al. Intercellular nanovesicle-mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth. Hepatology. 2011;54:1237-1248.
108. Ekstrom K, Valadi H, Sjostrand M, et al. Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells. J Extracell Vesicles. 2012 Apr 16. [Epub ahead of print].
109. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281-297.
110. Esquela-Kerscher A, Slack FJ. On-comirs: microRNAs with a role in cancer. Nat Rev Cancer. 2006;6: 259-269.
111. Gertsch J, Guttinger M, Sticher O, et al. Relative quantification of mRNA levels in Jurkat T cells with RT-real time-PCR (RT-rt-PCR): new possibilities for the screening of anti-inflammatory and cytotoxic compounds. Pharm Res. 2002;19
112. Eldh M, Lotvall J, Malmhall C, et al. Importance of RNA isolation methods for analysis of exosomal RNA: evaluation of different methods. Mol Immunol. 2012;50:278-286.
113. de Planell-Saguer M, Rodicio MC. Detection methods for microRNAs in clinic practice. Clin Biochem. 2013;46:869-878.
114. Chen C, Ridzon DA, Broomer AJ, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005;33:e179.
115. Crescitelli R, Lasser C, Szabo TG, et al. Distinct RNA profiles in sub-populations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes. J Extracell Vesicles. 2013 Sep 12. [Epub ahead of print].
116. Lasser C. Identification and analysis of circulating exosomal microRNA in human body fluids. Methods Mol Biol. 2013;1024:109-128.
117. Choi DS, Kim DK, Kim YK, et al. Proteomics, transcriptomics and lip-idomics of exosomes and ectosomes. Proteomics. 2013;13:1554-1571 .
118. Choi DS, Kim DK, Kim YK, et al. Proteomics of extracellular vesicles: exosomes and ectosomes. Mass Spectrom Rev. 2014 Jan 14. [Epub ahead of print].
119. Simpson RJ, Kalra H, Mathivanan S. ExoCarta as a resource for exo-somal research. J Extracell Vesicles. 2012 Apr 16. [Epub ahead of print].
120. Kim DK, Kang B, Kim OY, et al. EVpedia: an integrated database of high-throughput data for systemic analyses of extracellular vesicles. J Extracell Vesicles. 2013 Mar:19. [Epub ahead of print].
121. Kalra H, Simpson RJ, Ji H, et al. Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol. 2012;10:e1001450.
122. Russo F, Di Bella S, Nigita G, et al. miRandola: extracellular circulating microRNAs database. PLoS One. 2012;7:e47786.
123. Lotvall J, Rajendran L, Gho YS, et al. The launch of Journal of Extracellular Vesicles (JEV), the official journal of the International Society for Extracellular Vesicles -about microvesicles, exosomes, ec-tosomes and other extracellular vesicles. J Extracell Vesicles. 2012 Apr 16. [Epub ahead of print].
124. Yu B, Zhang X, Li X. Exosomes derived from mesenchymal stem cells. Int J Mol Sci. 2014;15:4142-4157.
125. Zitvogel L, Regnault A, Lozier A, et al. Eradication of established mur-ine tumors using a novel cell-free vaccine: dendritic cell-derived exo-somes. Nat Med. 1998;4:594-600. (Pubitemid 28237359)
126. Andre F, Chaput N, Schartz NE, et al. Exosomes as potent cell-free peptide-based vaccine, I: dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells. J Immunol. 2004;172:2126-2136. (Pubitemid 38182358)